Welcome to the Obesity resource hub. Here you will find resources to help you to support your patients.
Mysimba Summary of Product Characteristics
Mysimba Physician Prescribing Checklist
Mysimba Leave Piece
ASOI Adult Obesity Treatment Guidelines
Mysimba Patient Profile
Mysimba Patient Booklet
The Touch Endocrinology Website
The Measure Me BMI app – A Paediatric Weight Management Tool
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions
IE-MYS-217(1), MYS-0454-001 01/26 DOP: January 2026
The information on this website is intended for Healthcare Professionals who reside in Ireland and Malta only.
Healthcare professionals who reside in Ireland are asked to report any suspected adverse events to: HPRA Pharmacovigilance via www.hpra.ie;
Adverse events should also be reported to Orexigen: +353 1800 849 099 or Currax.Ml@primevigilance.com.
Healthcare professionals who reside in Malta are asked to report any suspected adverse events to: the Malta Medicines Authority via http://medicinesauthority.gov.mt/adrportal or Vivian Corporation Ltd. via pv@viviancorp.com.
Adverse events should also be reported to Orexigen: +356 800 62176 or Currax.Ml@primevigilance.com.